Cytokine-Mediated Programmed Proliferation of Virus-Specific CD8+ Memory T Cells

Immunity

Volumn 38, Issue 1, 2013, Pages 131-139

  Raué, Hans Peter ^a   Beadling, Carol ^b   Haun, Jennifer ^a   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOLYSIS; IN VITRO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VIREMIA;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; EPITOPES, T-LYMPHOCYTE; IMMUNOLOGIC MEMORY; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VIRUSES;

EID: 84872800101     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.09.019     Document Type: Article

References (52)

1. Andreasen S.O., Christensen J.E., Marker O., Thomsen A.R. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J. Immunol. 2000, 164:3689-3697.
2. Auphan-Anezin N., Verdeil G., Schmitt-Verhulst A.M. Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division. J. Immunol. 2003, 170:2442-2448.
3. Bajénoff M., Wurtz O., Guerder S. Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J. Immunol. 2002, 168:1723-1729.
4. Beadling C., Slifka M.K. Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines. Blood 2005, 105:1179-1186.
5. Belz G.T., Xie W., Doherty P.C. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J. Immunol. 2001, 166:4627-4633.
6. Berg R.E., Cordes C.J., Forman J. Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 2002, 32:2807-2816.
7. Berg R.E., Crossley E., Murray S., Forman J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 2003, 198:1583-1593.
8. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998, 9:229-237.
9. Borrow P., Tishon A., Lee S., Xu J., Grewal I.S., Oldstone M.B., Flavell R.A. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 1996, 183:2129-2142.
10. Brehm M.A., Pinto A.K., Daniels K.A., Schneck J.P., Welsh R.M., Selin L.K. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 2002, 3:627-634.
11. Butz E.A., Bevan M.J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998, 8:167-175.
12. Carroll H.P., Paunovic V., Gadina M. Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology (Oxford) 2008, 47:1269-1277.
13. Ehl S., Hombach J., Aichele P., Hengartner H., Zinkernagel R.M. Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 1997, 185:1241-1251.
14. Elsaesser H., Sauer K., Brooks D.G. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
15. Feau S., Arens R., Togher S., Schoenberger S.P. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat. Immunol. 2011, 12:908-913.
16. Freeman B.E., Hammarlund E., Raué H.P., Slifka M.K. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. USA 2012, 109:9971-9976.
17. Gagnon J., Ramanathan S., Leblanc C., Cloutier A., McDonald P.P., Ilangumaran S. IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes. J. Immunol. 2008, 180:7958-7968.
18. Goldrath A.W., Bogatzki L.Y., Bevan M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 2000, 192:557-564.
19. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2001, 2:415-422.
20. Kambayashi T., Assarsson E., Lukacher A.E., Ljunggren H.G., Jensen P.E. Memory CD8+ T cells provide an early source of IFN-gamma. J. Immunol. 2003, 170:2399-2408.
21. Kim S.K., Brehm M.A., Welsh R.M., Selin L.K. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J. Immunol. 2002, 169:90-98.
22. Lertmemongkolchai G., Cai G., Hunter C.A., Bancroft G.J. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J. Immunol. 2001, 166:1097-1105.
23. Masopust D., Kaech S.M., Wherry E.J., Ahmed R. The role of programming in memory T-cell development. Curr. Opin. Immunol. 2004, 16:217-225.
24. Masopust D., Murali-Krishna K., Ahmed R. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J. Virol. 2007, 81:2002-2011.
25. Matloubian M., Concepcion R.J., Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 1994, 68:8056-8063.
26. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G. Early programming of T cell populations responding to bacterial infection. J. Immunol. 2000, 165:6833-6839.
27. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., Murali-Krishna K., Mahar P.L., Edupuganti S., Lalor S., et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008, 28:710-722.
28. Murali-Krishna K., Ahmed R. Cutting edge: Naive T cells masquerading as memory cells. J. Immunol. 2000, 165:1733-1737.
29. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J.D., Zajac A.J., Miller J.D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187.
30. Murali-Krishna K., Lau L.L., Sambhara S., Lemonnier F., Altman J., Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999, 286:1377-1381.
31. Nguyen K.B., Biron C.A. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for NK and T cell IFN-γ production. J. Immunol. 1999, 162:5238-5246.
32. Opferman J.T., Ober B.T., Ashton-Rickardt P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 1999, 283:1745-1748.
33. Pipkin M.E., Sacks J.A., Cruz-Guilloty F., Lichtenheld M.G., Bevan M.J., Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32:79-90.
34. Raué H.P., Brien J.D., Hammarlund E., Slifka M.K. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J. Immunol. 2004, 173:6873-6881.
35. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300:337-339.
36. Shiow L.R., Rosen D.B., Brdicková N., Xu Y., An J., Lanier L.L., Cyster J.G., Matloubian M. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
37. Slifka M.K., Whitton J.L. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 2000, 164:208-216.
38. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu. Rev. Immunol. 2009, 27:591-619.
39. Spierings D.C., Lemmens E.E., Grewal K., Schoenberger S.P., Green D.R. Duration of CTL activation regulates IL-2 production required for autonomous clonal expansion. Eur. J. Immunol. 2006, 36:1707-1717.
40. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300:339-342.
41. Tough D.F., Sun S., Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 1997, 185:2089-2094.
42. Tough D.F., Zhang X., Sprent J. An IFN-gamma-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-gamma. J. Immunol. 2001, 166:6007-6011.
43. van Stipdonk M.J., Lemmens E.E., Schoenberger S.P. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2001, 2:423-429.
44. van Stipdonk M.J., Hardenberg G., Bijker M.S., Lemmens E.E., Droin N.M., Green D.R., Schoenberger S.P. Dynamic programming of CD8+ T lymphocyte responses. Nat. Immunol. 2003, 4:361-365.
45. Verdeil G., Chaix J., Schmitt-Verhulst A.M., Auphan-Anezin N. Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation. Eur. J. Immunol. 2006, 36:3090-3100.
46. von Herrath M.G., Yokoyama M., Dockter J., Oldstone M.B.A., Whitton J.L. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 1996, 70:1072-1079.
47. Waldmann T.A. The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006, 6:595-601.
48. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 2004, 202:139-156.
49. Whitmire J.K., Slifka M.K., Grewal I.S., Flavell R.A., Ahmed R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 1996, 70:8375-8381.
50. Wong P., Pamer E.G. Cutting edge: Antigen-independent CD8 T cell proliferation. J. Immunol. 2001, 166:5864-5868.
51. Wong P., Pamer E.G. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. J. Immunol. 2004, 172:2171-2176.
52. Yi J.S., Du M., Zajac A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576.